You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pegylated

Showing 1 - 25 of 1,416
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

Recruiting
  • Polycythemia Vera
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
May 19, 2023

Platinum-resistant Ovarian Cancer

Not yet recruiting
  • Ovarian Cancer
  • pegylated liposomal doxorubicin
  • (no location specified)
Aug 2, 2023

Kaposi Sarcoma, HIV-1-infection Trial (Pegylated liposomal doxorubicin, Paclitaxel)

Not yet recruiting
  • Kaposi Sarcoma
  • HIV-1-infection
  • (no location specified)
Jan 20, 2023

Ovarian Cancer Recurrent Trial in Beijing (IN10018, Placebo of IN10018, Pegylated Liposomal Doxorubicin)

Recruiting
  • Ovarian Cancer Recurrent
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Science and Peking Un
Aug 23, 2023

Prostate Cancer Trial in Houston (ADI-PEG 20, Cabazitaxel, Carboplatin)

Not yet recruiting
  • Prostate Cancer
  • ADI-PEG 20
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 16, 2023

Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)

Not yet recruiting
  • Myelofibrosis
  • Pegylated interferon alpha2a
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Sep 6, 2022

COVID-19, COVID Trial in Boston (Pegylated interferon lambda)

Terminated
Has Results
  • COVID-19
  • COVID
  • Pegylated interferon lambda
  • Boston, Massachusetts
    Massachusetts General Hospital
Jun 29, 2022

Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

Recruiting
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • +5 more
  • Shanghai, China
    Shanghai Pudong Hospital
Dec 11, 2022

Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

Recruiting
  • Essential Thrombocytopenia
  • Recombinant Interferon Alpha
  • Pegylated interferon alfa-2b
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 18, 2022

Small Cell Lung Cancer, Extra-Pulmonary Small Cell Carcinomas Trial run by the NCI (PLX038, Rucaparib)

Active, not recruiting
  • Small Cell Lung Cancer
  • Extra-Pulmonary Small Cell Carcinomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

PEGylated GH for Treatment of Short Stature in Chinese

Recruiting
  • Growth Hormone Treatment
  • Growth Disorders
  • Polyethylene glycol recombinant human growth hormone injection
  • Beijing, Beijing, China
    Department of Endocrinology, Genetics, Metabolism
Sep 12, 2023

Growth Hormone Deficiency Trial in Wuhan (Y-shape pegylated somatropin, Norditropin®, Norditropin)

Recruiting
  • Growth Hormone Deficiency
  • Y-shape pegylated somatropin
  • +2 more
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College of HUST
Feb 7, 2022

Breast Cancer Trial in Shanghai (sintilimab, bevacizumab biosimilar, pegylated liposomal doxorubicin)

Recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
May 22, 2022

Lymphoma, B-Cell Trial in Guangzhou (Rituximab Biosimilar, Pegylated Interferon a-2b)

Recruiting
  • Lymphoma, B-Cell
  • Rituximab Biosimilar
  • Pegylated Interferon α-2b
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-sen University Cancer Ce
Apr 6, 2022

Hepatitis D, Chronic Trial in Israel, New Zealand, Pakistan (Peginterferon Lambda-1A)

Completed
Has Results
  • Hepatitis D, Chronic
  • Peginterferon Lambda-1A
  • Beersheba, Israel
  • +3 more
Dec 20, 2022

Breast Cancer Trial in Tucson, Albuquerque (Pegylated liposomal doxorubicin)

Completed
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • Tucson, Arizona
  • +1 more
Jan 9, 2023

Breast Cancer Trial in Paris, Barcelone, Madrid (Trastuzumab and non-pegylated liposomal doxorubicin)

Completed
Has Results
  • Breast Cancer
  • Trastuzumab and non-pegylated liposomal doxorubicin
  • Paris, France
  • +3 more
Feb 8, 2022

Malignant Melanoma Trial in San Diego, Memphis, Houston (Peginterferon alfa-2b, Temozolomide, Recombinant interferon alfa-2b)

Active, not recruiting
Has Results
  • Malignant Melanoma
  • Peginterferon alfa-2b
  • +2 more
  • San Diego, California
  • +2 more
Apr 1, 2022

Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)

Completed
Has Results
  • Juvenile Pilocytic Astrocytomas
  • Optic Pathway Gliomas
  • Pegylated interferon alpha-2b
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Jan 18, 2022

Lymphoma Trial in Changchun (PEG-rhG-CSF, RhG-CSF)

Not yet recruiting
  • Lymphoma
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Apr 18, 2023

Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer Trial (Pegylated Liposomal Doxorubicin +

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • Pegylated Liposomal Doxorubicin + SL-172154
  • Mirvetuximab + SL-172154
  • (no location specified)
Jul 29, 2022

COVID-19 Trial in Be'er Sheva (Lambda 180 mcg S.C)

Recruiting
  • COVID-19
  • Lambda 180 mcg S.C
  • Be'er Sheva, Israel
    Soroka UMC
Jan 27, 2022

Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)

Recruiting
  • Hepatitis B, Chronic
  • PEGylated recombinant human interferon alpha-2b injection
  • Hefei, Anhui, China
    The First Affiliated Hospital of Anhui Medical University
Jun 24, 2023

Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

Completed
  • Chronic Hepatitis B
  • PegIFN α- 2b
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 11, 2022

Ulcerative Colitis, Crohn's Disease Trial in Herston (HM201, Placebo)

Recruiting
  • Ulcerative Colitis
  • Crohn's Disease
  • Herston, Queensland, Australia
    Nucleus Network Pty Ltd
Apr 19, 2022